Tag: data integrity

DI Considerations in R&D and Tech Transfer Labs Feeding Regulated Data Data Integrity Considerations in R&D and Tech Transfer Laboratories Feeding Regulated Data In the pharmaceutical industry, assuring data integrity throughout every phase of drug development and manufacturing is essential to meet the requirements of regulatory authorities in the US, UK, and EU. Laboratories involved…

Read More “DI Considerations in R&D and Tech Transfer Labs Feeding Regulated Data” »

Ensuring Data Integrity in Vendor-Hosted Stability, LIMS and EM Platforms How to Ensure Data Integrity in Vendor-Hosted Stability, LIMS, and Electronic Management Platforms Data integrity remains a cornerstone of pharmaceutical Good Manufacturing Practice (GMP), impacting product quality, patient safety, and regulatory compliance. The increasing reliance on vendor-hosted systems—for stability studies, laboratory information management systems (LIMS),…

Read More “Ensuring Data Integrity in Vendor-Hosted Stability, LIMS and EM Platforms” »

DI in Serialisation, Track-and-Trace and Supply Chain Data Flows: A Comprehensive GMP Tutorial Data Integrity in Serialisation, Track-and-Trace, and Supply Chain Data Flows: A Step-by-Step GMP Tutorial In pharmaceutical manufacturing and supply chain management, robust data integrity underpins product quality, patient safety, and regulatory compliance. Particularly critical are serialisation, track-and-trace systems, and end-to-end supply chain…

Read More “DI in Serialisation, Track-and-Trace and Supply Chain Data Flows” »

Copy–Paste Risks and Template Misuse: Preventing Data Integrity Violations in Documentation Step-by-Step Guide to Prevent Copy–Paste Risks and Template Misuse in Pharmaceutical Documentation In the pharmaceutical industry, data integrity is a cornerstone of compliance with regulatory requirements and the assurance of patient safety. The widespread use of electronic documentation and templated records, while improving efficiency,…

Read More “Copy–Paste Risks and Template Misuse: Preventing DI Violations in Documentation” »

Addressing Data Integrity Findings Cited in FDA Warning Letters and 483s Step-by-Step Guide to Addressing Data Integrity Findings in FDA Warning Letters and 483s Data integrity remains a central pillar in pharmaceutical Good Manufacturing Practice (GMP) compliance frameworks globally. Regulatory agencies such as the FDA, EMA, and MHRA consistently emphasize the critical importance of data…

Read More “Addressing Data Integrity Findings Cited in FDA Warning Letters and 483s” »

Aligning DI Remediation With Corporate Digital and Automation Strategy Step-by-Step Guide to Aligning Data Integrity Remediation With Corporate Digital and Automation Strategies in Pharma In the ever-evolving pharmaceutical industry, ensuring data integrity is paramount to complying with regulatory requirements and maintaining patient safety. The integration of DI remediation into corporate digital and automation strategies has…

Read More “Aligning DI Remediation With Corporate Digital and Automation Strategy” »

Major Data Integrity Failures: Case Studies and Regulatory Consequences Understanding Major Data Integrity Failures: Regulatory Impact and Compliance Strategies Data integrity stands as a pillar of Good Manufacturing Practice (GMP) compliance within pharmaceutical manufacturing and clinical operations. Ensuring trustworthy, accurate, and complete data underpins patient safety, product quality, and regulatory adherence. Over recent years, regulators…

Read More “Major Data Integrity Failures: Case Studies and Regulatory Consequences” »

Building a Data Integrity Maturity Model and Roadmap for the Site How to Build a Data Integrity Maturity Model and Roadmap for Your Pharma Site Ensuring data integrity within pharmaceutical manufacturing sites is critical to maintain product quality, patient safety, and regulatory compliance. For professionals in pharma QA, regulatory affairs, clinical operations, and medical affairs,…

Read More “Building a Data Integrity Maturity Model and Roadmap for the Site” »

Handling “Unknown User” and “System” Entries in Audit Trails: A Comprehensive Guide Step-by-Step Guide to Handling “Unknown User” and “System” Entries in Audit Trails for Pharmaceutical Data Integrity In pharmaceutical manufacturing and clinical operations regulated by 21 CFR Part 11, Annex 11, and various Good Manufacturing Practice (GMP) frameworks, maintaining robust data integrity within electronic…

Read More “Handling “Unknown User” and “System” Entries in Audit Trails” »

Data Integrity Controls for Third-Party Applications Used in GMP Context Implementing Data Integrity Controls for Third-Party Applications in GMP Environments Pharmaceutical companies increasingly rely on third-party applications to support Good Manufacturing Practice (GMP) operations, including electronic batch records, laboratory information management systems (LIMS), and manufacturing execution systems (MES). While these systems offer functionality and efficiency,…

Read More “Data Integrity Controls for Third-Party Applications Used in GMP Context” »